Víctor Cervera-Carrascón
PhD, VP Scientific Affairs and External Strategy
Víctor Cervera-Carrascón, serves as Vice President (Scientific Affairs & External Strategy) at TILT Biotherapeutics. He brings over a decade of experience in oncology and immuno-oncology, spanning translational research, clinical development, business development, external partnerships, and scientific strategy. Víctor has played a key role in advancing TILT’s oncolytic immunotherapy platform from preclinical development into Phase II clinical trials and works closely with pharmaceutical partners, investors, and other external stakeholders.